Abstract:Background: In our previous studies, we have demonstrated that insulin-like growth factor binding protein-related protein1 (IGFBP-rP1) played its potential tumor suppressor role in colon cancer cells through apoptosis and senescence induction. In this study, we will further uncover the role of IGFBP-rP1 in colon cancer differentiation and a possible mechanism by revealing responsible genes.Results: In normal colon epithelium, immunohistochemistry staining detected a gradient IGFBP-rP1 expression along the axis of the crypt. IGFBP-rP1 strongly expressed in the differentiated cells at the surface of the colon epithelium, while weakly expressed at the crypt base. In colon cancer tissues, the expression of IGFBP-rP1 correlated positively with the differentiation status. IGFBP-rP1 strongly expressed in low grade colorectal carcinoma and weakly expressed in high grade colorectal carcinoma. In vitro, transfection of PcDNA3.1(IGFBP-rP1) into RKO, SW620 and CW2 cells induced a more pronounced anterior-posterior polarity morphology, accompanied by upregulation with alkaline phosphatase (AKP) activity. Upregulation of carcino-embryonic antigen (CEA) was also observed in SW620 and CW2 transfectants. The addition of IGFBP-rP1 protein into the medium could mimic most but not all effects of IGFBP-rP1 cDNA transfection. Seventy-eight reproducibly differentially expressed genes were detected in PcDNA3.1(IGFBP-rP1)-RKO transfectants, using Affymetrix 133 plus 2.0 expression chip platform. Directed Acyclic Graph (DAG) of the enriched GO categories demonstrated that differential expression of the enzyme regulator activity genes together with cytoskeleton and actin binding genes were significant. IGFBP-rP1 could upreguate Transgelin (TAGLN), downregulate SRY (sex determining region Y)-box 9(campomelic dysplasia, autosomal sex-reversal) (SOX9), insulin receptor substrate 1(IRS1), cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4) (CDKN2B), amphiregulin(schwannoma-derived growth factor) (AREG) and immediate early response 5-like (IER5L) in RKO, SW620 and CW2 colon cancer cells, verified by Real time Reverse Transcription Polymerase Chain Reaction (rtRT-PCR). During sodium butyrate-induced Caco2 cell differentiation, IGFBP-rP1 was upregulated and the expression showed significant correlation with the AKP activity. The downregulation of IRS1 and SOX9 were also induced by sodium butyrate.Conclusion: IGFBP-rP1 was a potential key molecule associated with colon cancer differentiation. Downregulation of IRS1 and SOX9 may the possible key downstream genes involved in the process.

Insulin-like growth factor binding protein-related protein 1 and cancer.

Igfbp-Rp1, A Potential Molecule Associated with Colon Cancer Differentiation

Tumor Suppressor Gene Insulin-Like Growth Factor Binding Protein-Related Protein 1 (Igfbp-Rp1) Induces Senescence-Like Growth Arrest in Colorectal Cancer Cells

Igfbp, A Novel Target of Lung Cancer?

Igfbp-Rp1 Acts As A Potential Tumor Suppressor Via the Suppression of Erk Signaling Pathway in Endometrial Cancer Cells

Insulin Growth Factor Binding Protein 7 (Igfbp7)-Related Cancer and IGFBP3 and IGFBP7 Crosstalk

Advance on insulin-like growth factor binding protein in human malignant tumors

Insulin-Like Growth Factor Binding Protein-1 Inhibits Cancer Cell Invasion And Is Associated With Poor Prognosis In Hepatocellular Carcinoma

The Oncogenic Functions of Insulin-like Growth Factor 2 mRNA-Binding Protein 3 in Human Carcinomas

Expression characteristics and their functional role of IGFBP gene family in pan-cancer

IGFBP7 plays a potential tumor suppressor role in colorectal carcinogenesis.

Pan-cancer Analysis of Oncogenic Role of Insulin-Like Growth Factor-Binding Proteins and Validation in Ovarian Cancer.

Research Progress of Insulin-Like Growth Factor Binding Protein IGFBP-3

IGFBP2: Integrative Hub of Developmental and Oncogenic Signaling Network

IGFBP-rP1 Suppresses Epithelial–mesenchymal Transition and Metastasis in Colorectal Cancer

The Roles of Insulin-Like Growth Factor Binding Protein Family in Development and Diseases

Insulin - like growth factor type 1 receptor and malignancy:An update

Secreted insulin-like growth factor binding protein 5 functions as a tumor suppressor and chemosensitizer through inhibiting insulin-like growth factor 1 receptor/protein kinase B pathway in acute myeloid leukemia

Research Progress on Physiological Function and Expression Regulation of Insulin-Like Growth Factor-Binding Protein-1

Targeting IGF2BP3 in Cancer

Insulin Growth Factor-2 Binding Protein 3 (igf2bp3) to Promote Lung Tumorigenesis Viaregulation of P53 Stability.